Prevention of colitis by controlled oral drug delivery of carbon monoxide-Reference-Cited by-同舟云学术

Prevention of colitis by controlled oral drug delivery of carbon monoxide

Published:2016-10 Issue: Volume:239 Page:128-136
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Steiger Christoph,Uchiyama Kazuhiko,Takagi Tomohisa,Mizushima Katsura,Higashimura Yasuki,Gutmann Marcus,Hermann Cornelius,Botov Svetlana,Schmalz Hans-Günther,Naito Yuji,Meinel Lorenz^ORCID

Funder

DAAD

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference64 articles.

1. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review;Molodecky;Gastroenterology,2012

2. Animal models of ulcerative colitis and their application in drug research;Low;Drug Des. Devel. Ther.,2013

3. The therapeutic potential of carbon monoxide;Motterlini;Nat. Rev. Drug Discov.,2010

4. Carbon monoxide reverses diabetic gastroparesis in NOD mice;Kashyap;Am. J. Physiol. Gastrointest. Liver Physiol.,2010

5. Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine;Moore;Gastroenterology,2003

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update of gut gas metabolism in ulcerative colitis;Expert Review of Gastroenterology & Hepatology;2024-07-02

2. Carbon monoxide as a cellular protective agent in a swine model of cardiac arrest protocol;PLOS ONE;2024-05-15

3. Inflammation Resolution Mediators: Future Prospects;Inflammation Resolution and Chronic Diseases;2024

4. Properties and cellular uptake of photo-triggered mixed metallosurfactant vesicles intended for controlled CO delivery in gas therapy;Colloids and Surfaces B: Biointerfaces;2023-08

5. Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis;ACS Applied Materials & Interfaces;2023-07-18